Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | KIT |
Variant | Y568_T574del |
Impact List | deletion |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | KIT Y568_T574del results in the deletion of seven amino acids in the juxtamembrane domain (exon 11) of the Kit protein from amino acids 568 to 574 (PMID: 16226710). Y568_T574del has not been characterized, however similar Kit exon 11 deletions are activating (PMID: 9438854, PMID: 15365079), and therefore, is predicted to lead to a gain of Kit protein function. |
Associated Drug Resistance | |
Category Variants Paths |
KIT mutant KIT act mut KIT exon 11 del KIT Y568_T574del KIT mutant KIT exon11 KIT exon 11 del KIT Y568_T574del |
Transcript | NM_000222.3 |
gDNA | chr4:g.54727470_54727490del21 |
cDNA | c.1702_1722del21 |
Protein | p.Y568_T574delYVYIDPT |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000222 | chr4:g.54727470_54727490del21 | c.1702_1722del21 | p.Y568_T574del | RefSeq | GRCh38/hg38 |
XM_017008178 | chr4:g.54727470_54727490del21 | c.1702_1722del21 | p.Y568_T574del | RefSeq | GRCh38/hg38 |
NM_000222.3 | chr4:g.54727470_54727490del21 | c.1702_1722del21 | p.Y568_T574delYVYIDPT | RefSeq | GRCh38/hg38 |
NM_001385285.1 | chr4:g.54727470_54727490del21 | c.1702_1722del21 | p.Y568_T574delYVYIDPT | RefSeq | GRCh38/hg38 |
NM_001093772.2 | chr4:g.54727484_54727504del21 | c.1704_1724del21 | p.P569_D575delPTQLPYD | RefSeq | GRCh38/hg38 |
XM_017008178.1 | chr4:g.54727470_54727490del21 | c.1702_1722del21 | p.Y568_T574del | RefSeq | GRCh38/hg38 |
NM_001385286.1 | chr4:g.54727484_54727504del21 | c.1704_1724del21 | p.P569_D575delPTQLPYD | RefSeq | GRCh38/hg38 |
NM_001385288.1 | chr4:g.54727479_54727499del21 | c.1702_1722del21 | p.I568_P574delIDPTQLP | RefSeq | GRCh38/hg38 |
NM_000222.2 | chr4:g.54727470_54727490del21 | c.1702_1722del21 | p.Y568_T574del | RefSeq | GRCh38/hg38 |
NM_001385292.1 | chr4:g.54727479_54727499del21 | c.1702_1722del21 | p.I568_P574delIDPTQLP | RefSeq | GRCh38/hg38 |
NM_001385290.1 | chr4:g.54727468_54727488del21 | c.1703_1723del21 | p.N568_P574delNYVYIDP | RefSeq | GRCh38/hg38 |
NM_001385284.1 | chr4:g.54727468_54727488del21 | c.1703_1723del21 | p.N568_P574delNYVYIDP | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|